BK6-11323-00523
3 vaccinations
3 coded responses
36 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 981 / WA
- Registered
- 2022-08-01
- Relationship
- Child or adolescent in my care
- Guardian
- 29M-19082-66023
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-08-01
Registered in v-safe
-
2022-08-01
Dose 1 — Pfizer-BioNTechCo-administered: Hepatitis B:Hib:Pneumonia:Polio:Rotavirus:Tetanus
- 2022-08-01
-
2022-08-02
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Sleepiness, Irritability/cryingUnder 3 check-in
- 2022-08-04
- 2022-08-05
- 2022-08-06
- 2022-08-07
- 2022-08-08
- 2022-08-15
-
2022-08-22
Dose 2 — Pfizer-BioNTech
- 2022-08-22
-
2022-08-23
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Sleepiness, Irritability/cryingUnder 3 check-in
- 2022-08-24
- 2022-08-25
- 2022-08-26
- 2022-08-27
- 2022-08-28
- 2022-08-29
- 2022-09-05
- 2022-09-12
- 2022-09-19
- 2022-09-26
- 2022-10-03
-
2022-11-03
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-11-03
-
2022-11-04
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Sleepiness, Irritability/cryingUnder 3 check-in
- 2022-11-05
- 2022-11-06
- 2022-11-07
- 2022-11-08
- 2022-11-09
- 2022-11-10
-
2022-11-17
Survey response — day 14, dose 3, under 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cold-like illness 11/13/22-11/15/22MedDRA releases: 2024-11 · check-in free text available
-
2022-11-24
Survey response — day 21, dose 3, under 3MedDRA: Pyrexia, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever 3 days up to 103.5, runny nose, congestion.MedDRA releases: 2024-11 · check-in free text available
- 2022-12-01
-
2022-12-08
Survey response — day 35, dose 3, under 3MedDRA: Lethargy, Malaise, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever 103.2, lethargy, malaiseMedDRA releases: 2024-11 · check-in free text available
- 2022-12-17
- 2023-02-04
- 2023-05-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-01 | Pfizer-BioNTech | Hepatitis B:Hib:Pneumonia:Polio:Rotavirus:Tetanus |
| 2 | 2022-08-22 | Pfizer-BioNTech | No |
| 3 | 2022-11-03 | Pfizer-BioNTech | Flu |
Free text
Release 12 (Under 3) — day 14, dose 3, under 3
Symptoms: Cold-like illness 11/13/22-11/15/22
Release 12 (Under 3) — day 21, dose 3, under 3
Symptoms: Fever 3 days up to 103.5, runny nose, congestion.
Release 12 (Under 3) — day 35, dose 3, under 3
Symptoms: Fever 103.2, lethargy, malaise
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Lethargy | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release